| 0 |
SENSORY PROCESSING SENSITIVITY |
1 |
0.0227 |
| 1 |
SYSTEMIC TOXICITY |
1 |
0.0049 |
| 2 |
PRODUCT ADHESION ISSUE |
163 |
0.0046 |
| 3 |
APPLICATION SITE MASS |
1 |
0.0036 |
| 4 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
4 |
0.0034 |
| 5 |
PHYSICAL EXAMINATION ABNORMAL |
1 |
0.0026 |
| 6 |
APPLICATION SITE EROSION |
3 |
0.0023 |
| 7 |
SITTING DISABILITY |
1 |
0.0016 |
| 8 |
BRONCHIAL SECRETION RETENTION |
2 |
0.0016 |
| 9 |
TRANSIENT GLOBAL AMNESIA |
1 |
0.0014 |
| 10 |
CLONIC CONVULSION |
1 |
0.0014 |
| 11 |
APTYALISM |
1 |
0.0012 |
| 12 |
SOLILOQUY |
1 |
0.0012 |
| 13 |
MOTION SICKNESS |
2 |
0.0010 |
| 14 |
APPLICATION SITE SCAB |
2 |
0.0009 |
| 15 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 16 |
APPLICATION SITE HAEMORRHAGE |
2 |
0.0007 |
| 17 |
GINGIVAL HYPERTROPHY |
1 |
0.0007 |
| 18 |
MYDRIASIS |
8 |
0.0006 |
| 19 |
SLEEP TALKING |
1 |
0.0006 |
| 20 |
ADENOCARCINOMA |
1 |
0.0004 |
| 21 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 22 |
APPLICATION SITE REACTION |
3 |
0.0004 |
| 23 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 24 |
APPLICATION SITE RASH |
5 |
0.0004 |
| 25 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 26 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 27 |
LUNG ADENOCARCINOMA |
1 |
0.0003 |
| 28 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 29 |
APPLICATION SITE IRRITATION |
4 |
0.0003 |
| 30 |
APPLICATION SITE VESICLES |
2 |
0.0003 |
| 31 |
SKIN WEEPING |
1 |
0.0003 |
| 32 |
FEELING DRUNK |
2 |
0.0003 |
| 33 |
POLYDIPSIA |
1 |
0.0003 |
| 34 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
51 |
0.0003 |
| 35 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 36 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 37 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 38 |
PRODUCT COMMUNICATION ISSUE |
2 |
0.0002 |
| 39 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 40 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 41 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0002 |
| 42 |
DRY THROAT |
2 |
0.0002 |
| 43 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 44 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 45 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 46 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 47 |
APPLICATION SITE PAIN |
4 |
0.0002 |
| 48 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 49 |
APPLICATION SITE PRURITUS |
4 |
0.0002 |
| 50 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 51 |
ILEUS |
2 |
0.0002 |
| 52 |
DRY MOUTH |
13 |
0.0002 |
| 53 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 54 |
VERTIGO |
9 |
0.0001 |
| 55 |
PRODUCT QUALITY ISSUE |
20 |
0.0001 |
| 56 |
DROOLING |
1 |
0.0001 |
| 57 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 58 |
MUSCLE INJURY |
1 |
0.0001 |
| 59 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 60 |
PARANOIA |
2 |
0.0001 |
| 61 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 62 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 63 |
HALLUCINATION |
8 |
0.0001 |
| 64 |
FEELING JITTERY |
2 |
0.0001 |
| 65 |
AFFECT LABILITY |
1 |
0.0001 |
| 66 |
PARKINSONISM |
1 |
0.0001 |
| 67 |
VISION BLURRED |
14 |
0.0001 |
| 68 |
HOSPICE CARE |
1 |
0.0001 |
| 69 |
DISORIENTATION |
4 |
0.0001 |
| 70 |
HYPOTONIA |
1 |
0.0001 |
| 71 |
EUPHORIC MOOD |
1 |
0.0001 |
| 72 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 73 |
OFF LABEL USE |
81 |
0.0001 |
| 74 |
REBOUND EFFECT |
1 |
0.0001 |
| 75 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 76 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 77 |
DIZZINESS |
37 |
0.0001 |
| 78 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
| 79 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 80 |
BALANCE DISORDER |
6 |
0.0001 |
| 81 |
MATERNAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 82 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 83 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 84 |
BRAIN FOG |
1 |
0.0001 |
| 85 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 86 |
GAIT INABILITY |
2 |
0.0001 |
| 87 |
ILLNESS |
6 |
0.0001 |
| 88 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
0.0001 |
| 89 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 90 |
TOOTHACHE |
1 |
0.0001 |
| 91 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 92 |
AGITATION |
4 |
0.0001 |
| 93 |
THINKING ABNORMAL |
1 |
0.0001 |
| 94 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 95 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 96 |
FEELING ABNORMAL |
12 |
0.0001 |
| 97 |
FEEDING DISORDER |
1 |
0.0000 |
| 98 |
DERMATITIS |
1 |
0.0000 |
| 99 |
RETCHING |
1 |
0.0000 |
| 100 |
AMNESIA |
3 |
0.0000 |
| 101 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 102 |
DIPLOPIA |
1 |
0.0000 |
| 103 |
SEDATION |
1 |
0.0000 |
| 104 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 105 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 106 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 107 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 108 |
EYE PAIN |
2 |
0.0000 |
| 109 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 110 |
NAUSEA |
28 |
0.0000 |
| 111 |
PAIN IN JAW |
1 |
0.0000 |
| 112 |
HYPERSOMNIA |
1 |
0.0000 |
| 113 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 114 |
APHASIA |
1 |
0.0000 |
| 115 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 116 |
DYSPEPSIA |
3 |
0.0000 |
| 117 |
TREMOR |
5 |
0.0000 |
| 118 |
URINARY RETENTION |
1 |
0.0000 |
| 119 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 120 |
DELIRIUM |
1 |
0.0000 |
| 121 |
SLEEP DISORDER |
2 |
0.0000 |
| 122 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 123 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 124 |
PANIC ATTACK |
1 |
0.0000 |
| 125 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 126 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 127 |
RESTLESSNESS |
1 |
0.0000 |
| 128 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 129 |
VOMITING |
11 |
0.0000 |
| 130 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 131 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 132 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 133 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 134 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 135 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 136 |
DRUG INEFFECTIVE |
28 |
0.0000 |
| 137 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 138 |
MALAISE |
9 |
0.0000 |
| 139 |
SPEECH DISORDER |
1 |
0.0000 |
| 140 |
BRADYCARDIA |
1 |
0.0000 |
| 141 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 142 |
WEIGHT DECREASED |
5 |
0.0000 |
| 143 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 144 |
BLISTER |
1 |
0.0000 |
| 145 |
PALPITATIONS |
2 |
0.0000 |
| 146 |
BONE PAIN |
1 |
0.0000 |
| 147 |
FEELING HOT |
1 |
0.0000 |
| 148 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 149 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 150 |
HYPERHIDROSIS |
2 |
0.0000 |
| 151 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 152 |
DEHYDRATION |
2 |
0.0000 |
| 153 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 154 |
DECREASED APPETITE |
3 |
0.0000 |
| 155 |
CARDIAC ARREST |
1 |
0.0000 |
| 156 |
FALL |
4 |
0.0000 |
| 157 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 158 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 159 |
ADVERSE EVENT |
1 |
0.0000 |
| 160 |
ANXIETY |
3 |
0.0000 |
| 161 |
DYSPHAGIA |
1 |
0.0000 |
| 162 |
PRURITUS |
4 |
0.0000 |
| 163 |
HEART RATE INCREASED |
1 |
0.0000 |
| 164 |
SOMNOLENCE |
2 |
0.0000 |
| 165 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 166 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 167 |
HEADACHE |
5 |
0.0000 |
| 168 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 169 |
FATIGUE |
6 |
0.0000 |
| 170 |
RASH |
3 |
0.0000 |
| 171 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 172 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 173 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 174 |
DIARRHOEA |
4 |
0.0000 |
| 175 |
URTICARIA |
1 |
0.0000 |
| 176 |
MYALGIA |
1 |
0.0000 |
| 177 |
DEATH |
5 |
0.0000 |
| 178 |
CHEST PAIN |
1 |
0.0000 |
| 179 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 180 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 181 |
ANAEMIA |
1 |
0.0000 |
| 182 |
ALOPECIA |
1 |
0.0000 |
| 183 |
ERYTHEMA |
1 |
0.0000 |
| 184 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 185 |
DEPRESSION |
1 |
0.0000 |
| 186 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 187 |
INSOMNIA |
1 |
0.0000 |
| 188 |
COUGH |
1 |
0.0000 |
| 189 |
PNEUMONIA |
1 |
0.0000 |
| 190 |
PYREXIA |
1 |
0.0000 |
| 191 |
ASTHENIA |
1 |
0.0000 |
| 192 |
PAIN |
1 |
0.0000 |